A.M. Aubertin

625 total citations
18 papers, 502 citations indexed

About

A.M. Aubertin is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, A.M. Aubertin has authored 18 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in A.M. Aubertin's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Virus-based gene therapy research (4 papers). A.M. Aubertin is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and Virus-based gene therapy research (4 papers). A.M. Aubertin collaborates with scholars based in France, United States and Germany. A.M. Aubertin's co-authors include A. Kirn, Isabelle Pellegrin, Christiane Moog, Hervé Fleury, T.N. Tham, V. Gregory Chinchar, Jian Mao, Glenn A. Gentry, Marie‐Paule Schmitt and Anne‐Marie Steffan and has published in prestigious journals such as Nucleic Acids Research, Journal of Virology and Virology.

In The Last Decade

A.M. Aubertin

18 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Aubertin France 12 270 238 191 117 92 18 502
Kersi Katrak United Kingdom 9 110 0.4× 130 0.5× 177 0.9× 116 1.0× 102 1.1× 10 458
Phil Markham United States 6 438 1.6× 243 1.0× 264 1.4× 179 1.5× 148 1.6× 8 672
George Dapolito United States 14 449 1.7× 203 0.9× 234 1.2× 363 3.1× 106 1.2× 15 706
Lyle M. Rudensey United States 10 580 2.1× 242 1.0× 338 1.8× 147 1.3× 125 1.4× 11 666
Aitziber Agirre Spain 8 213 0.8× 107 0.4× 165 0.9× 154 1.3× 330 3.6× 9 598
D P Burns United States 10 557 2.1× 211 0.9× 290 1.5× 212 1.8× 91 1.0× 12 645
Lesley McLain United Kingdom 16 253 0.9× 198 0.8× 225 1.2× 271 2.3× 198 2.2× 24 761
Cirilo D. Cabradilla United States 6 552 2.0× 229 1.0× 322 1.7× 213 1.8× 219 2.4× 7 810
Linda Whetter United States 12 114 0.4× 83 0.3× 250 1.3× 129 1.1× 170 1.8× 18 665
M F Saron France 13 66 0.2× 257 1.1× 220 1.2× 136 1.2× 151 1.6× 24 609

Countries citing papers authored by A.M. Aubertin

Since Specialization
Citations

This map shows the geographic impact of A.M. Aubertin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Aubertin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Aubertin more than expected).

Fields of papers citing papers by A.M. Aubertin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Aubertin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Aubertin. The network helps show where A.M. Aubertin may publish in the future.

Co-authorship network of co-authors of A.M. Aubertin

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Aubertin. A scholar is included among the top collaborators of A.M. Aubertin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Aubertin. A.M. Aubertin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mee, Edward, Neil Berry, Claire Ham, et al.. (2010). Mhc haplotype M3 is associated with early control of SHIVsbg infection in Mauritian cynomolgus macaques. Tissue Antigens. 76(3). 223–229. 17 indexed citations
2.
Meier, Chris, A.M. Aubertin, M. De Monte, et al.. (1998). Synthesis and Antiviral Evaluation of SATE-Foscarnet Prodrugs and New Foscarnet—AZT Conjugates. Antiviral chemistry & chemotherapy. 9(1). 41–52. 21 indexed citations
3.
Moog, Christiane, Hervé Fleury, Isabelle Pellegrin, A. Kirn, & A.M. Aubertin. (1997). Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals. Journal of Virology. 71(5). 3734–3741. 178 indexed citations
4.
Mao, Jian, T.N. Tham, Glenn A. Gentry, A.M. Aubertin, & V. Gregory Chinchar. (1996). Cloning, Sequence Analysis, and Expression of the Major Capsid Protein of the Iridovirus Frog Virus 3. Virology. 216(2). 431–436. 89 indexed citations
5.
Benzaria, S., Hélène Pelicano, Georges Maury, et al.. (1995). New Prodrugs of 9-(2-Phosphonomethoxyethyl)adenine [PMEA]: Synthesis and Stability Studies. Nucleosides Nucleotides & Nucleic Acids. 14(3). 563–565. 3 indexed citations
6.
Gosselin, Gilles, Christophe Mathé, A.M. Aubertin, et al.. (1995). ChemInform Abstract: 2′‐ and/or 3′‐Deoxy‐β‐L‐pentofuranosyl Nucleoside Derivatives: Stereospecific Synthesis and Antiviral Activities.. ChemInform. 26(40). 1 indexed citations
7.
Liška, Vladimír, Danièle Spehner, Majid Mehtali, et al.. (1994). Localization of Viral protein X in Simian Immunodeficiency Virus Macaque Strain and Analysis of its Packaging Requirements. Journal of General Virology. 75(11). 2955–2962. 15 indexed citations
8.
Schmitt, Marie‐Paule, Christine Schweitzer, Anne‐Marie Steffan, et al.. (1990). Permissivity of Primary Cultures of Human Kupffer Cells for HIV-1. AIDS Research and Human Retroviruses. 6(8). 987–991. 43 indexed citations
9.
Schmitt, Marie‐Paule, Anne‐Marie Steffan, D Jaeck, et al.. (1990). Multiplication of human immunodeficiency virus in primary cultures of human kupffer cells—possible role of liver macrophage infection in the physiopathology of aids. Research in Virology. 141(2). 143–152. 26 indexed citations
10.
Schmitt, Marie‐Paule, et al.. (1990). The nucleotide sequence of a delayed early gene (31K) of frog virus 3. Nucleic Acids Research. 18(13). 4000–4000. 11 indexed citations
11.
Tham, T.N., et al.. (1988). Molecular cloning and physical and translational mapping of the frog virus 3 genome. Virology. 162(1). 108–117. 11 indexed citations
12.
Mesnard, Jean-Michel, et al.. (1988). Organization of RNA transcripts from a 7.8-kb region of the frog virus 3 genome. Virology. 165(1). 122–133. 4 indexed citations
13.
Tham, T.N., et al.. (1988). Structure and regulation of the immediate-early frog virus 3 gene that encodes ICR489. Journal of Virology. 62(4). 1271–1277. 29 indexed citations
14.
Aubertin, A.M., et al.. (1986). Restriction of frog virus 3 polypeptide synthesis to immediate early and delayed early species by supraoptimal temperatures. Virology. 152(2). 355–364. 5 indexed citations
15.
Martin, J.P., et al.. (1984). Fate of Frog Virus 3 DNA Replicated in the Nucleus of Arginine-deprived CHO Cells. Journal of General Virology. 65(4). 721–732. 13 indexed citations
16.
Martin, J.P., A.M. Aubertin, & A. Kirn. (1982). Expression of frog virus 3 early genes after ultraviolet irradiation. Virology. 122(2). 402–410. 11 indexed citations
17.
Aubertin, A.M., et al.. (1981). Inhibition de la traduction par le FV3: Action des protéines virales de structure solubilisées sur la synthèse protéique in vivo et in vitro. Annales de l Institut Pasteur Virologie. 132(1). 25–39. 8 indexed citations
18.
Aubertin, A.M., C. Travo, & A. Kirn. (1976). Proteins solubilized from frog virus 3 particles: effect on transcription. Journal of Virology. 18(1). 34–41. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026